Access our on-demand webinar to learn about sequencing of the SARS-CoV-2 genome on the GenapSys™ platform

Saurabh 0.7 x0.7

Dr. Saurabh Paliwal, Associate Director, Molecular Biology & NGS Applications at GenapSys shared:

  • a truly decentralized and low cost NGS solution for surveillance and testing for the COVID-19 pandemic
  • the platform's compatibility with diverse library preparation assays – from hybrid capture panels to multiplex PCR amplicon panels
  • the platform's detection accuracy of SARS-CoV-2 variants – including a wide range of viral titers, even at low read coverages

If you have any questions regarding the GenapSys sequencing platform, please contact us at www.genapsys.com.